645 related articles for article (PubMed ID: 33297404)
1. NEK1 Phosphorylation of YAP Promotes Its Stabilization and Transcriptional Output.
Khalil MI; Ghosh I; Singh V; Chen J; Zhu H; De Benedetti A
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33297404
[TBL] [Abstract][Full Text] [Related]
2. Targeting the TLK1/NEK1 DDR axis with Thioridazine suppresses outgrowth of androgen independent prostate tumors.
Singh V; Jaiswal PK; Ghosh I; Koul HK; Yu X; De Benedetti A
Int J Cancer; 2019 Aug; 145(4):1055-1067. PubMed ID: 30737777
[TBL] [Abstract][Full Text] [Related]
3. The TLK1-Nek1 axis promotes prostate cancer progression.
Singh V; Jaiswal PK; Ghosh I; Koul HK; Yu X; De Benedetti A
Cancer Lett; 2019 Jul; 453():131-141. PubMed ID: 30928383
[TBL] [Abstract][Full Text] [Related]
4. NEK1-Mediated Phosphorylation of YAP1 Is Key to Prostate Cancer Progression.
Ghosh I; Khalil MI; Mirza R; King J; Olatunde D; De Benedetti A
Biomedicines; 2023 Feb; 11(3):. PubMed ID: 36979713
[TBL] [Abstract][Full Text] [Related]
5. Tousled-like kinase 1: a novel factor with multifaceted role in mCRPC progression and development of therapy resistance.
Khalil MI; De Benedetti A
Cancer Drug Resist; 2022; 5(1):93-101. PubMed ID: 35582542
[TBL] [Abstract][Full Text] [Related]
6. The TLK1/Nek1 axis contributes to mitochondrial integrity and apoptosis prevention via phosphorylation of VDAC1.
Singh V; Khalil MI; De Benedetti A
Cell Cycle; 2020 Feb; 19(3):363-375. PubMed ID: 31914854
[TBL] [Abstract][Full Text] [Related]
7. Identification of the proteome complement of humanTLK1 reveals it binds and phosphorylates NEK1 regulating its activity.
Singh V; Connelly ZM; Shen X; De Benedetti A
Cell Cycle; 2017 May; 16(10):915-926. PubMed ID: 28426283
[TBL] [Abstract][Full Text] [Related]
8. TLK1-mediated MK5-S354 phosphorylation drives prostate cancer cell motility and may signify distinct pathologies.
Khalil MI; Singh V; King J; De Benedetti A
Mol Oncol; 2022 Jul; 16(13):2537-2557. PubMed ID: 35064619
[TBL] [Abstract][Full Text] [Related]
9. Generation of Phenothiazine with Potent Anti-TLK1 Activity for Prostate Cancer Therapy.
Singh V; Bhoir S; Chikhale RV; Hussain J; Dwyer D; Bryce RA; Kirubakaran S; De Benedetti A
iScience; 2020 Sep; 23(9):101474. PubMed ID: 32905878
[TBL] [Abstract][Full Text] [Related]
10. Interaction of TLK1 and AKTIP as a Potential Regulator of AKT Activation in Castration-Resistant Prostate Cancer Progression.
Khalil MI; Madere C; Ghosh I; Adam RM; De Benedetti A
Pathophysiology; 2021 Jul; 28(3):339-354. PubMed ID: 35366279
[TBL] [Abstract][Full Text] [Related]
11. Nek1 silencing slows down DNA repair and blocks DNA damage-induced cell cycle arrest.
Pelegrini AL; Moura DJ; Brenner BL; Ledur PF; Maques GP; Henriques JA; Saffi J; Lenz G
Mutagenesis; 2010 Sep; 25(5):447-54. PubMed ID: 20501547
[TBL] [Abstract][Full Text] [Related]
12. The TLK1-MK5 Axis Regulates Motility, Invasion, and Metastasis of Prostate Cancer Cells.
Khalil MI; De Benedetti A
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497211
[TBL] [Abstract][Full Text] [Related]
13. YAP1 and AR interactions contribute to the switch from androgen-dependent to castration-resistant growth in prostate cancer.
Kuser-Abali G; Alptekin A; Lewis M; Garraway IP; Cinar B
Nat Commun; 2015 Sep; 6():8126. PubMed ID: 28230103
[TBL] [Abstract][Full Text] [Related]
14. YAP1 regulates prostate cancer stem cell-like characteristics to promote castration resistant growth.
Jiang N; Ke B; Hjort-Jensen K; Iglesias-Gato D; Wang Z; Chang P; Zhao Y; Niu X; Wu T; Peng B; Jiang M; Li X; Shang Z; Wang Q; Chang C; Flores-Morales A; Niu Y
Oncotarget; 2017 Dec; 8(70):115054-115067. PubMed ID: 29383141
[TBL] [Abstract][Full Text] [Related]
15. Increased Nek1 expression in renal cell carcinoma cells is associated with decreased sensitivity to DNA-damaging treatment.
Chen Y; Chen CF; Polci R; Wei R; Riley DJ; Chen PL
Oncotarget; 2014 Jun; 5(12):4283-94. PubMed ID: 24970796
[TBL] [Abstract][Full Text] [Related]
16. The metabolic role of PFKFB4 in androgen-independent growth in vitro and PFKFB4 expression in human prostate cancer tissue.
Li X; Chen Z; Li Z; Huang G; Lin J; Wei Q; Liang J; Li W
BMC Urol; 2020 Jun; 20(1):61. PubMed ID: 32487245
[TBL] [Abstract][Full Text] [Related]
17. Nek1 shares structural and functional similarities with NIMA kinase.
Feige E; Shalom O; Tsuriel S; Yissachar N; Motro B
Biochim Biophys Acta; 2006 Mar; 1763(3):272-81. PubMed ID: 16603261
[TBL] [Abstract][Full Text] [Related]
18. Never-in-mitosis related kinase 1 functions in DNA damage response and checkpoint control.
Chen Y; Chen PL; Chen CF; Jiang X; Riley DJ
Cell Cycle; 2008 Oct; 7(20):3194-201. PubMed ID: 18843199
[TBL] [Abstract][Full Text] [Related]
19. NIMA-related protein kinase 1 is involved early in the ionizing radiation-induced DNA damage response.
Polci R; Peng A; Chen PL; Riley DJ; Chen Y
Cancer Res; 2004 Dec; 64(24):8800-3. PubMed ID: 15604234
[TBL] [Abstract][Full Text] [Related]
20. YAP1 Is Involved in Tumorigenic Properties of Prostate Cancer Cells.
Collak FK; Demir U; Sagir F
Pathol Oncol Res; 2020 Apr; 26(2):867-876. PubMed ID: 30859486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
